Israel Active

Israel’s BioLight Life Sciences Investments announced that its CellDetect non-invasive test for detecting bladder cancer in urine has obtained CE Marking, enabling the product to be marketed and sold in Europe and other countries.

Israeli biotech Pharma Two B has announced positive results in its Phase IIb pivotal clinical study of P2B001 for the treatment of early stage Parkinson’s disease. The tests combined two low dose chemicals that separately had limited effect and were dangerous in high dosages.

Scientists from Tel Aviv University and Israeli medical centers have developed a groundbreaking method for sealing the incisions in the eye following cornea transplant surgery. They used silver halide optical fibers to deliver an infrared laser beam at the precise temperature needed to bond the tissue.

A rare positive report on Israel by the BBC . Weizmann scientists have discovered that whereas normal children spend longer inhaling the aroma of roses than that of rotten fish, autistic children don’t differentiate between pleasant and unpleasant odors.

A team of international scientists, including researchers from Tel Aviv University and Israel’s Interuniversity Institute for Marine Sciences (IUI), have discovered that fluorescent pigments in Eilat’s rainbow coral are ideal for use as biomedical markers for tracking cancer cells.

A report by the Organization for Economic Co-operation and Development ranked Israel's mortality rate for cardiovascular disease (less than 200 per 100,000 population) the fourth-lowest among OECD nations. Japan was the lowest, followed by France and South Korea.

I reported previously on Israel’s MyMDBand - a wristband with a QR code that gives paramedics access to vital patient data. Here now are two latest videos about the exciting product.

Tel Aviv University Professor Udi Qimron has published his research about bacterial viruses (phages) that attack bacteria. The phages transfer "edited" DNA into resistant bacteria to kill off resistant strains and make others more sensitive to antibiotics. Clinical tests will begin soon.

Canada’s Finance Minister Joe Oliver announced a seven-year, $35-million program will fund up to 30 joint Canadian-Israeli research projects. The first projects will focus on neuroscience, with up to six $1 million grants per year for up to three years.

Top scientists from the Ontario Institute for Cancer Research (OICR), the Hebrew University in Jerusalem and Sheba Medical Center in Tel Hashomer are working together on the Alex U. Soyka Pancreatic Cancer Research Project. The OICR is giving $4.6 million to the project.